The potential impact of COVID-19-related disruption on tuberculosis burden
Before the coronavirus disease 2019 (COVID-19) pandemic, over 4000 people were dying from tuberculosis (TB) every day [1]. As with past emergencies [2], the impact of COVID-19 on TB outcomes is a serious cause for concern [3] but is currently unknown. Health system overload, due to high numbers of C...
Saved in:
Published in | The European respiratory journal Vol. 56; no. 2; p. 2001718 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
European Respiratory Society
01.08.2020
|
Subjects | |
Online Access | Get full text |
ISSN | 0903-1936 1399-3003 1399-3003 |
DOI | 10.1183/13993003.01718-2020 |
Cover
Abstract | Before the coronavirus disease 2019 (COVID-19) pandemic, over 4000 people were dying from tuberculosis (TB) every day [1]. As with past emergencies [2], the impact of COVID-19 on TB outcomes is a serious cause for concern [3] but is currently unknown. Health system overload, due to high numbers of COVID-19 cases, as well as interventions necessary to limit the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), could result in severe reductions in health service availability and access for the detection and treatment of TB cases [4]. However, physical distancing interventions could also limit
Mycobacterium tuberculosis
transmission outside of households, where most transmission occurs [5]. This has not been adequately explored in concurrent work [6–8], and it is currently unclear whether social distancing could compensate for disruptions in TB services, and what the impact of these combined COVID-19 disruption effects on TB burden is likely to be.
Any benefit of social distancing on TB deaths is likely to be outweighed by health service disruption. As such, it is crucially important to maintain and strengthen TB-related health services during, and after, the COVID-19 pandemic.
https://bit.ly/30aWZnp |
---|---|
AbstractList | Before the coronavirus disease 2019 (COVID-19) pandemic, over 4000 people were dying from tuberculosis (TB) every day [1]. As with past emergencies [2], the impact of COVID-19 on TB outcomes is a serious cause for concern [3] but is currently unknown. Health system overload, due to high numbers of COVID-19 cases, as well as interventions necessary to limit the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), could result in severe reductions in health service availability and access for the detection and treatment of TB cases [4]. However, physical distancing interventions could also limit
Mycobacterium tuberculosis
transmission outside of households, where most transmission occurs [5]. This has not been adequately explored in concurrent work [6–8], and it is currently unclear whether social distancing could compensate for disruptions in TB services, and what the impact of these combined COVID-19 disruption effects on TB burden is likely to be.
Any benefit of social distancing on TB deaths is likely to be outweighed by health service disruption. As such, it is crucially important to maintain and strengthen TB-related health services during, and after, the COVID-19 pandemic.
https://bit.ly/30aWZnp |
Author | McQuaid, C. Finn Houben, Rein M.G.J. White, Richard G. McCreesh, Nicky Harris, Rebecca C. Read, Jonathan M. Sumner, Tom |
AuthorAffiliation | 4 A list of members of the CMMID COVID-19 Working Group can be found in the acknowledgements section 2 Center for Health Informatics Computing and Statistics, Lancaster Medical School, Lancaster University, Lancaster, UK 1 TB Modelling Group, TB Centre, and Centre for Mathematical Modelling of Infectious Diseases, Dept of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK 3 Sanofi Pasteur, Singapore |
AuthorAffiliation_xml | – name: 2 Center for Health Informatics Computing and Statistics, Lancaster Medical School, Lancaster University, Lancaster, UK – name: 1 TB Modelling Group, TB Centre, and Centre for Mathematical Modelling of Infectious Diseases, Dept of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK – name: 3 Sanofi Pasteur, Singapore – name: 4 A list of members of the CMMID COVID-19 Working Group can be found in the acknowledgements section |
Author_xml | – sequence: 1 givenname: C. Finn surname: McQuaid fullname: McQuaid, C. Finn – sequence: 2 givenname: Nicky surname: McCreesh fullname: McCreesh, Nicky – sequence: 3 givenname: Jonathan M. surname: Read fullname: Read, Jonathan M. – sequence: 4 givenname: Tom surname: Sumner fullname: Sumner, Tom – sequence: 5 givenname: Rein M.G.J. orcidid: 0000-0003-4132-7467 surname: Houben fullname: Houben, Rein M.G.J. – sequence: 6 givenname: Richard G. surname: White fullname: White, Richard G. – sequence: 7 givenname: Rebecca C. surname: Harris fullname: Harris, Rebecca C. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32513784$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UUtLxDAQDqLo-vgFgvTopZo0bZJeBFnfCHtZvYY0mWqk29QkFfz3pr5QD8LAwMz3GObbRuu96wGhfYKPCBH0mNC6phjTI0w4EXmBC7yGZtM0n8braIZrTHNSU7aFtkN4wpiwkpJNtEWLilAuyhm6WT5CNrgIfbSqy-xqUDpmrs3mi_vrs0TOPXQqgsmMDX4conV9liqODXg9di7YkDWjN9Dvoo1WdQH2PvsOurs4X86v8tvF5fX89DbXVVXFXGiuONW8ZaoqedOoUlAMnLHSmJYbwTA3LQMBreZl3UJRg2FFw4XWdVESSnfQyYfuMDYrMDqd7lUnB29Xyr9Kp6z8vento3xwL5IXXFS4TAKHnwLePY8QolzZoKHrVA9uDDK5EIIZx1WCHvz0-jb5emAC0A-A9i4ED-03hGA5xSS_YpLvMckppsSq_7C0jWr6bTrYdv9y3wDiupbF |
CitedBy_id | crossref_primary_10_1093_cid_ciac455 crossref_primary_10_3390_medsci11040063 crossref_primary_10_3390_microorganisms9061158 crossref_primary_10_1136_bmjopen_2023_071799 crossref_primary_10_1136_thorax_2023_220047 crossref_primary_10_1371_journal_pgph_0003043 crossref_primary_10_3390_life12101468 crossref_primary_10_1080_23744235_2020_1806353 crossref_primary_10_3390_hygiene3010001 crossref_primary_10_1080_07853890_2022_2160491 crossref_primary_10_1371_journal_pgph_0000219 crossref_primary_10_1016_j_jeph_2024_202795 crossref_primary_10_1017_dmp_2022_142 crossref_primary_10_2807_1560_7917_ES_2021_26_24_2100231 crossref_primary_10_3389_ftubr_2024_1438406 crossref_primary_10_1146_annurev_economics_051520_025412 crossref_primary_10_1111_joim_13197 crossref_primary_10_1186_s12913_021_06852_z crossref_primary_10_1016_j_jctube_2020_100199 crossref_primary_10_1016_j_arbres_2021_05_035 crossref_primary_10_1183_13993003_03890_2020 crossref_primary_10_1111_1462_2920_15217 crossref_primary_10_1007_s12038_025_00496_5 crossref_primary_10_3346_jkms_2020_35_e388 crossref_primary_10_1038_s44259_024_00066_z crossref_primary_10_4103_ijmr_IJMR_326_21 crossref_primary_10_1108_IJOPH_09_2020_0067 crossref_primary_10_5812_jjm_134575 crossref_primary_10_34215_1609_1175_2022_4_43_48 crossref_primary_10_1007_s00431_023_04981_7 crossref_primary_10_3346_jkms_2023_38_e43 crossref_primary_10_3389_fcimb_2022_929689 crossref_primary_10_3389_fimmu_2021_641378 crossref_primary_10_3390_biom13020248 crossref_primary_10_1016_j_regg_2021_04_007 crossref_primary_10_1016_j_ijregi_2022_12_008 crossref_primary_10_1016_S2214_109X_23_00312_1 crossref_primary_10_3390_polym14132577 crossref_primary_10_9745_GHSP_D_21_00368 crossref_primary_10_1016_S1473_3099_24_00007_0 crossref_primary_10_1038_s41598_022_18135_6 crossref_primary_10_1016_j_arbres_2020_11_016 crossref_primary_10_3390_antibiotics10060693 crossref_primary_10_1007_s11356_022_22849_5 crossref_primary_10_1159_000516509 crossref_primary_10_3389_fpubh_2021_644536 crossref_primary_10_1038_d41586_020_02334_0 crossref_primary_10_1055_a_1351_9176 crossref_primary_10_2147_IDR_S428652 crossref_primary_10_7759_cureus_60412 crossref_primary_10_1080_14740338_2023_2205638 crossref_primary_10_3390_antibiotics11111622 crossref_primary_10_3389_fmed_2022_971008 crossref_primary_10_3390_pathogens13060491 crossref_primary_10_12688_f1000research_28318_1 crossref_primary_10_22270_jddt_v14i12_6915 crossref_primary_10_12688_f1000research_28318_2 crossref_primary_10_1016_S2213_2600_21_00020_5 crossref_primary_10_1186_s12889_021_12142_4 crossref_primary_10_1016_j_epidem_2022_100540 crossref_primary_10_1038_s41579_022_00731_y crossref_primary_10_1186_s43168_022_00117_x crossref_primary_10_1016_S0140_6736_20_32138_3 crossref_primary_10_2478_amtsb_2021_0025 crossref_primary_10_1016_j_mmifmc_2022_03_338 crossref_primary_10_3390_idr17010011 crossref_primary_10_3389_fpubh_2022_937844 crossref_primary_10_1038_s41591_022_01750_1 crossref_primary_10_1016_j_ijid_2021_08_055 crossref_primary_10_1177_2333794X231156048 crossref_primary_10_1183_13993003_02538_2021 crossref_primary_10_1016_j_actatropica_2022_106776 crossref_primary_10_1093_trstmh_traa067 crossref_primary_10_1186_s40249_024_01188_2 crossref_primary_10_1016_j_jiac_2021_06_021 crossref_primary_10_1016_S2213_2600_20_30392_1 crossref_primary_10_24171_j_phrp_2021_0063 crossref_primary_10_1016_j_jiac_2023_09_018 crossref_primary_10_12688_f1000research_53385_1 crossref_primary_10_3390_vaccines9111228 crossref_primary_10_2807_1560_7917_ES_2021_26_24_2100426 crossref_primary_10_3390_tropicalmed7090247 crossref_primary_10_1371_journal_pmed_1003675 crossref_primary_10_1590_0102_311x00094520 crossref_primary_10_3390_ijms241612709 crossref_primary_10_2196_35994 crossref_primary_10_1080_17476348_2021_1924682 crossref_primary_10_2185_jrm_2021_039 crossref_primary_10_1016_j_lanwpc_2020_100032 crossref_primary_10_1016_j_lansea_2022_04_007 crossref_primary_10_1186_s12916_021_02063_9 crossref_primary_10_1016_j_ijtb_2021_07_014 crossref_primary_10_1016_j_ijtb_2024_11_005 crossref_primary_10_1016_S2214_109X_22_00414_4 crossref_primary_10_1038_s43856_022_00145_0 crossref_primary_10_1186_s13256_021_03193_7 crossref_primary_10_1186_s12879_024_10244_z crossref_primary_10_1016_j_hjdsi_2020_100487 crossref_primary_10_1186_s13063_021_05331_4 crossref_primary_10_1183_13993003_02710_2020 crossref_primary_10_1136_bmjgh_2021_007456 crossref_primary_10_1371_journal_pone_0249822 crossref_primary_10_3390_antibiotics10030272 crossref_primary_10_1186_s13031_020_00325_6 crossref_primary_10_5588_ijtldopen_24_0194 crossref_primary_10_1183_16000617_0264_2021 crossref_primary_10_2196_29463 crossref_primary_10_1371_journal_pone_0291404 crossref_primary_10_1002_iid3_981 crossref_primary_10_1002_ardp_202300187 crossref_primary_10_1016_j_rmr_2020_09_006 crossref_primary_10_15252_emmm_202114088 crossref_primary_10_1007_s40475_021_00241_6 crossref_primary_10_2139_ssrn_4057232 crossref_primary_10_2174_1871526522666220407001744 crossref_primary_10_3389_fcimb_2021_624607 crossref_primary_10_1183_23120541_00507_2020 crossref_primary_10_1186_s12913_022_08855_w crossref_primary_10_1016_S0140_6736_23_01379_X crossref_primary_10_1186_s12916_022_02624_6 crossref_primary_10_1371_journal_pgph_0000150 crossref_primary_10_1016_j_eclinm_2020_100603 crossref_primary_10_1186_s12992_021_00666_8 crossref_primary_10_5205_1981_8963_2024_261495 crossref_primary_10_1371_journal_pone_0273389 crossref_primary_10_1038_s41467_023_37314_1 crossref_primary_10_1371_journal_pgph_0003309 crossref_primary_10_1016_j_jctube_2022_100335 crossref_primary_10_1186_s40981_021_00467_3 crossref_primary_10_15212_ZOONOSES_2021_0021 crossref_primary_10_3390_diagnostics11122221 crossref_primary_10_1016_j_tube_2020_102020 crossref_primary_10_1016_j_jiph_2021_07_001 crossref_primary_10_1016_j_pulmoe_2022_04_012 crossref_primary_10_26787_nydha_2686_6838_2022_24_4_64_69 crossref_primary_10_1007_s44197_023_00085_5 crossref_primary_10_1016_j_arbres_2021_05_014 crossref_primary_10_1136_bmjgh_2021_007878 crossref_primary_10_1371_journal_pone_0269458 crossref_primary_10_1016_j_lfs_2024_122778 crossref_primary_10_1016_S2213_2600_22_00092_3 crossref_primary_10_1186_s40249_024_01223_2 crossref_primary_10_1016_j_hsr_2023_100128 crossref_primary_10_1016_j_tube_2022_102202 crossref_primary_10_1371_journal_pgph_0001018 crossref_primary_10_3390_ijms23042235 crossref_primary_10_3390_diagnostics14070698 crossref_primary_10_3390_jpm13121629 crossref_primary_10_21292_2075_1230_2022_100_9_46_58 crossref_primary_10_1128_spectrum_00090_23 crossref_primary_10_4103_ijcfm_ijcfm_61_22 crossref_primary_10_3389_fmed_2022_905245 |
Cites_doi | 10.3201/eid2203.150977 10.1183/13993003.01398-2020 10.1016/S2213-2600(20)30151-X 10.1101/2020.04.28.20079582 10.1101/2020.03.19.20039107 10.5588/ijtld.20.0127 10.1016/S2214-109X(18)30452-2 10.1016/j.pulmoe.2020.05.002 10.1371/journal.pone.0132840 |
ContentType | Journal Article |
Copyright | Copyright ©ERS 2020. 2020 |
Copyright_xml | – notice: Copyright ©ERS 2020. 2020 |
CorporateAuthor | CMMID COVID-19 Working Group |
CorporateAuthor_xml | – name: CMMID COVID-19 Working Group |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1183/13993003.01718-2020 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Potential impact of COVID-19-related disruption on TB burden |
EISSN | 1399-3003 |
ExternalDocumentID | PMC7278504 32513784 10_1183_13993003_01718_2020 |
Genre | Letter Review Correspondence |
GrantInformation_xml | – fundername: Medical Research Council grantid: MR/P002404/1 – fundername: Medical Research Council grantid: MR/V038613/1 |
GroupedDBID | --- .55 .GJ 18M 1OC 2WC 31~ 3O- 53G 5GY 5RE 5VS 8-1 AADJU AAFWJ AAYXX AAZMJ ABCQX ABJNI ABOCM ABSQV ACEMG ACGFO ACPRK ACXQS ADBBV ADDZX ADMOG ADYFA AENEX AFFNX AFHIN AFZJQ AIZTS AJAOE ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CAG CITATION COF CS3 DIK E3Z EBS EJD F5P F9R GX1 H13 INIJC J5H KQ8 L7B LH4 LW6 OK1 P2P PQQKQ R0Z RHI TER TR2 W8F WOQ X7M ZE2 ZGI ZXP ~02 CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c555t-8c7a73c7f6a547bba4830e7664ddf7d8607df6e8efc749fe29ed62b78cc924133 |
ISSN | 0903-1936 1399-3003 |
IngestDate | Thu Aug 21 17:12:42 EDT 2025 Fri Sep 05 14:10:03 EDT 2025 Sat May 31 02:12:43 EDT 2025 Tue Aug 05 12:07:09 EDT 2025 Thu Apr 24 22:50:55 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c555t-8c7a73c7f6a547bba4830e7664ddf7d8607df6e8efc749fe29ed62b78cc924133 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 23 ObjectType-Review-2 |
ORCID | 0000-0003-4132-7467 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7278504 |
PMID | 32513784 |
PQID | 2411106705 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7278504 proquest_miscellaneous_2411106705 pubmed_primary_32513784 crossref_primary_10_1183_13993003_01718_2020 crossref_citationtrail_10_1183_13993003_01718_2020 |
PublicationCentury | 2000 |
PublicationDate | 2020-08-01 |
PublicationDateYYYYMMDD | 2020-08-01 |
PublicationDate_xml | – month: 08 year: 2020 text: 2020-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | The European respiratory journal |
PublicationTitleAlternate | Eur Respir J |
PublicationYear | 2020 |
Publisher | European Respiratory Society |
Publisher_xml | – name: European Respiratory Society |
References | 2024102101461492000_56.2.2001718.6 2024102101461492000_56.2.2001718.7 2024102101461492000_56.2.2001718.8 2024102101461492000_56.2.2001718.9 Pang (2024102101461492000_56.2.2001718.4) 2020; 24 2024102101461492000_56.2.2001718.15 2024102101461492000_56.2.2001718.2 2024102101461492000_56.2.2001718.1 Motta (2024102101461492000_56.2.2001718.16) 2020; 26 Glynn (2024102101461492000_56.2.2001718.5) 2015; 10 Wingfield (2024102101461492000_56.2.2001718.3) 2020; 8 2024102101461492000_56.2.2001718.10 Harris (2024102101461492000_56.2.2001718.13) 2019; 7 2024102101461492000_56.2.2001718.11 2024102101461492000_56.2.2001718.12 2024102101461492000_56.2.2001718.14 32703778 - Eur Respir J. 2020 Sep 24;56(3):2002710. doi: 10.1183/13993003.02710-2020. |
References_xml | – ident: 2024102101461492000_56.2.2001718.6 – ident: 2024102101461492000_56.2.2001718.8 – ident: 2024102101461492000_56.2.2001718.2 doi: 10.3201/eid2203.150977 – ident: 2024102101461492000_56.2.2001718.14 – ident: 2024102101461492000_56.2.2001718.15 doi: 10.1183/13993003.01398-2020 – ident: 2024102101461492000_56.2.2001718.1 – ident: 2024102101461492000_56.2.2001718.11 – ident: 2024102101461492000_56.2.2001718.12 – ident: 2024102101461492000_56.2.2001718.10 – volume: 8 start-page: 536 year: 2020 ident: 2024102101461492000_56.2.2001718.3 article-title: Tackling two pandemics: a plea on World Tuberculosis Day publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30151-X – ident: 2024102101461492000_56.2.2001718.7 doi: 10.1101/2020.04.28.20079582 – ident: 2024102101461492000_56.2.2001718.9 doi: 10.1101/2020.03.19.20039107 – volume: 24 start-page: 545 year: 2020 ident: 2024102101461492000_56.2.2001718.4 article-title: Impact of COVID-19 on tuberculosis control in China publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.20.0127 – volume: 7 start-page: e209 year: 2019 ident: 2024102101461492000_56.2.2001718.13 article-title: Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(18)30452-2 – volume: 26 start-page: 233 year: 2020 ident: 2024102101461492000_56.2.2001718.16 article-title: Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts publication-title: Pulmonology doi: 10.1016/j.pulmoe.2020.05.002 – volume: 10 start-page: e0132840 year: 2015 ident: 2024102101461492000_56.2.2001718.5 article-title: Whole genome sequencing shows a low proportion of tuberculosis disease is attributable to known close contacts in rural Malawi publication-title: PloS One doi: 10.1371/journal.pone.0132840 – reference: 32703778 - Eur Respir J. 2020 Sep 24;56(3):2002710. doi: 10.1183/13993003.02710-2020. |
SSID | ssj0016431 |
Score | 2.6625388 |
SecondaryResourceType | review_article |
Snippet | Before the coronavirus disease 2019 (COVID-19) pandemic, over 4000 people were dying from tuberculosis (TB) every day [1]. As with past emergencies [2], the... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2001718 |
SubjectTerms | Agora Antitubercular Agents - therapeutic use Communicable Disease Control - organization & administration Comorbidity Coronavirus Infections - epidemiology Coronavirus Infections - prevention & control Cost of Illness COVID-19 Female Global Health Humans Incidence Male Pandemics - prevention & control Pandemics - statistics & numerical data Pneumonia, Viral - epidemiology Pneumonia, Viral - prevention & control Risk Assessment Tuberculosis, Pulmonary - diagnosis Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - epidemiology |
Title | The potential impact of COVID-19-related disruption on tuberculosis burden |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32513784 https://www.proquest.com/docview/2411106705 https://pubmed.ncbi.nlm.nih.gov/PMC7278504 |
Volume | 56 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAviDvlpiDxNlzS2I6dR1SYxqSChjq0tyi-RKsYyZQmLzzyyzl2Eict1cSQqqhK3CPH56t9fC6fEXqrtchhXRNYZRnDlCqGRR7NsRQytucxauOYmJZf4uMzenLOzieT36OspaaWM_Vrb13J_2gV7oFebZXsDTTrhcIN-A76hStoGK7_rOOrsrYJP5Y7wxc8Lr5-__wRzxPsKlXApNTrTdW0k4MNDjTSVKq5LC0ZiXR1DGMb1Ur1TvpqFIof98m58k6bbO0QspgdHq2LYniyqIzZXHRQ--Hd9t86RPU--8PlbIhK_exqb1btSPW-iGjIhPNORZvplpCO3LqdUsEEwiQMyXjObcnEO2xF4wnUEfiI_ZO7sCQTVp4VN3MNse3GsJb18fudJc4nHrotjyBpLyR1QlIr5Ba6HXGwv2xg_3SIRIHF5k5d7N-sY64CIe_39GTbuvlry7KbeTsyZVb30b1uDxJ8aAH1AE1M8RDdWXZZFo_QCSAg8LgKWlwFZR7s4ioYcBXAZ4yroMXVY3R29Gm1OMbdmRtYMcZqLBTPOFE8jzNGuZQZFSQ0MC5U65xrEYdc57ERJlecJrmJEqPjSHKhVGJDtOQJOijKwjxDQSJhLdCaG8UNlXGSwCCZecJFRjTLaT5FUT9WqeoI6e25KJfpNVqaonf-R1ctH8v1zd_0Skhh3rTBsKwwZbNJobNzS58Ysil62irFCyRg9BMu6BTxLXX5BpaTfftJsb5w3OywHRAspM9v1s0X6O7wd3qJDuqqMa_A2K3la4fGP5GAoYc |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+potential+impact+of+COVID-19-related+disruption+on+tuberculosis+burden&rft.jtitle=The+European+respiratory+journal&rft.au=McQuaid%2C+C.+Finn&rft.au=McCreesh%2C+Nicky&rft.au=Read%2C+Jonathan+M.&rft.au=Sumner%2C+Tom&rft.date=2020-08-01&rft.issn=0903-1936&rft.eissn=1399-3003&rft.volume=56&rft.issue=2&rft.spage=2001718&rft_id=info:doi/10.1183%2F13993003.01718-2020&rft.externalDBID=n%2Fa&rft.externalDocID=10_1183_13993003_01718_2020 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon |